InvestorsHub Logo
Followers 26
Posts 2879
Boards Moderated 0
Alias Born 12/05/2021

Re: pgsd post# 434661

Thursday, 01/13/2022 5:30:59 AM

Thursday, January 13, 2022 5:30:59 AM

Post# of 701435

This argument would be laughed out of court for one reason in particular - COVID



Such lawsuits would be dismissed because legally a shareholder needs to first summon the NIH to summon NWBO to uphold that rule and if the NIH does not adhere you could try to sue the NIH to summon NWBO.

But I am 100% sure NIHs rebuttal will be that NWBO did not update the clinical website with the trial completion date so the NIH officially has no knowledge of NWBO's completion date or if there is any. Therefore anyone must first summon the NIH to summon NWBO to update its clinical website with the completion date.

Also I'm 100% sure NWBO did NOT request an extension of the 1-year deadline for any reason, COVID or not, for if they would ask the NIH for an extension the NIH would reply that NBO first has to update the clinical website with the study completion date before they can request an extension. Since the 1 year after the study completion date has long passed that ship has sailed.

Just interesting to know

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News